Development of nanoparticles based on amphiphilic cyclodextrins for the delivery of active substances.
Augis L, Nerbø Reiten I, Førde JL, Casas-Solvas JM, Sizun C, Bizien T, Rajkovic I, Larquet E, Michelet A, Collot M, Lesieur S, Herfindal L, Legrand FX.
Augis L, et al. Among authors: herfindal l.
Int J Pharm. 2024 Feb 15;651:123723. doi: 10.1016/j.ijpharm.2023.123723. Epub 2023 Dec 17.
Int J Pharm. 2024.
PMID: 38110013